- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07575451
Empowering Families in Pediatric Cardiovascular Surgery: A RAM-Based Approach
Evaluation of a Nursing Program Based on Roy's Adaptation Model for Empowering Families of Children Aged 1 to 3 Years Post-Cardiac Surgery
The purpose of this clinical trial is to learn about the effects of a nursing support program designed for families of children aged 1 to 3 years who have undergone heart surgery. This program aims to improve parents' caregiving skills and support the healthy growth of their children.
The primary questions the study aims to answer are:
Does the nursing program positively affect the physical growth of children, such as their height and weight?
Does the program improve children's scores on general development tests (Denver II)?
Do parents' attitudes toward child feeding and their confidence in parenting skills increase?
Researchers will divide participants into two groups:
Experimental Group: Families who participate in the nursing education program and receive an informative booklet.
Control Group: Families who only receive an informative booklet and continue with routine hospital follow-ups.
The researchers will compare these two groups to see if participating in the nursing program leads to better results for the children's development and the families' skills.
Participants will be asked to:
Attend 5 different education and counseling sessions, starting one week before surgery and continuing until the child reaches 1 year of follow-up.
Meet with the researcher at specific intervals (at 1, 2, 3, 6, 9, and 12 months) for one year to monitor the child's development (height, weight, head circumference) and skills.
Complete surveys regarding child feeding attitudes and parenting skills at the 6th and 12th month follow-ups.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Detailed Description
- Study Rationale and Objectives This study is designed as an experimental research project to evaluate the effectiveness of a nursing empowerment program based on Roy's Adaptation Model (RAM). The primary objective is to empower the families of children aged 1 to 3 years who have undergone cardiovascular surgery and to examine the impact of this empowerment on the children's growth, development, and parental outcomes.
- Study Design and Setting Design: Prospective, randomized controlled experimental trial.Study Sites: Çukurova University Faculty of Medicine Balcalı Hospital and Adana City Training and Research Hospital (Pediatric Cardiovascular Surgery Departments).Timeframe: June 15, 2026 - June 15, 2027.
Participants and Randomization Universe: All families of children aged 1-3 years undergoing heart surgery at the specified hospitals during the study period.
Sample Size: Calculated using G*Power 3.1.9.2 (Effect size $f = 0.25$, $\alpha = 0.05$, power $= 0.80$).Randomization: Participants will be assigned to either the Experimental Group or the Control Group using a simple random number table. Homogeneity between groups will be verified via Chi-square and t-tests regarding baseline demographics (age, education, income).
- Interventions Experimental Group (Empowerment Program):Families will participate in the "RAM-Based Family Empowerment Program."The program consists of 5 structured sessions:Pre-operative (1 week before): Preparation and baseline assessment.Post-operative (First day in ward): Post-op counseling and support.1st Month Follow-up: First follow-up education session.2nd Month Follow-up: Second follow-up education session.3rd Month Follow-up: Final structured education session.Educational materials include a RAM-based booklet, brochures, and visual aids (videos/posters) focusing on physiological, self-concept, role function, and interdependence modes.Control Group:Families will receive routine hospital care.A "RAM-Based Post-Cardiac Surgery Family Empowerment Booklet" will be provided as a baseline resource, but no structured counseling sessions will be conducted.
- Data Collection and Follow-up Schedule All measurements and evaluations throughout the study will be performed face-to-face by the same researcher to ensure data consistency and reliability. The data collection process begins with a Baseline (Pre-operative) assessment conducted one week before surgery, where all tools-including the Sociodemographic and Anthropometric Data Form, the RAM-Based Assessment Form, the Denver II Developmental Screening Test, the Maternal Attitudes Toward Feeding Process Scale (MAFPS), and the Parental Self-Efficacy Scale-are administered to the participants. Following the intervention, a structured follow-up schedule is implemented to monitor the child's physical growth and the family's adaptation process. During the 1st, 2nd, 3rd, and 9th months post-operatively, researchers will perform anthropometric measurements (including height, weight, head circumference, and BMI) and the Denver II test to track developmental progress. At the 6th and 12th-month follow-ups, a comprehensive full assessment will be conducted; this includes a repeat of all anthropometric measurements and the Denver II test, along with the re-administration of the MAFPS for mothers and the Parental Self-Efficacy Scale for both mothers and fathers to evaluate long-term parental outcomes and the sustained effectiveness of the empowerment program.
- Pilot Study A pilot study will be conducted with 10 families to test the clarity of the educational content and the duration of data collection tools. Pilot participants will be excluded from the main study analysis.
- Statistical Analysis Data will be analyzed using IBM SPSS 28.Descriptive Statistics: Mean, standard deviation, frequency, and percentage.Group Comparisons: Independent t-test or Mann-Whitney U test.Pre-Post Comparisons: Paired t-test or Wilcoxon test.Multi-Factorial Analysis: Repeated Measures ANOVA to evaluate the change over time between groups.Significance Level: $p < 0.05$.
- Ethical Considerations Ethical approval has been obtained from the Çukurova University Clinical Research Ethics Committee. Written informed consent will be obtained from all participating families. Confidentiality and anonymity of participant data will be strictly maintained. No physical or psychological risks are anticipated for the participants.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Kübra Türker, PhD Student
- Número de teléfono: +905357416538
- Correo electrónico: kubrakadah@hotmail.com
Copia de seguridad de contactos de estudio
- Nombre: Şenay Çetinkaya, Prof. Dr.
- Correo electrónico: scetinkaya@cu.edu.tr
Ubicaciones de estudio
-
-
Adana
-
Adana, Adana, Turquía (Türkiye), 01330
- Cukurova University
-
Contacto:
- Kübra Türker, PhD
- Número de teléfono: +905357416538
- Correo electrónico: kubrakadah@hotmail.com
-
Contacto:
- Şenay Çetinkaya, Prof. Dr.
- Número de teléfono: +905353492958
- Correo electrónico: scetinkaya@cu.edu.tr
-
Investigador principal:
- Şenay Çetinkaya, Prof. Dr.
-
Adana, Adana, Turquía (Türkiye), 01300
- Adana City Training and Research Hospital
-
Contacto:
- Kübra Türker, PhD Student
- Número de teléfono: +905357416538
- Correo electrónico: kubrakadah@hotmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Families who agree to participate in the study and sign the informed consent form.
- Families of children aged 1-3 years in the preoperative period who are scheduled to undergo cardiac surgery due to congenital heart disease.
- Families who do not speak or read Turkish but will undergo cardiac surgery due to congenital heart disease will also be included in the study with the assistance of an interpreter.
- Families who are over 18 years of age and have access to a mobile phone or internet at home.
Exclusion Criteria:
- Exclusion criteria include the presence of additional congenital malformations, dysmorphic syndromes, chromosomal or endocrine disorders, severe infection, hypothyroidism, or any similar conditions that could lead to growth and developmental delay in the child, alongside congenital heart disease
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental Group
Families of children aged 1-3 who participate in the RAM-based nursing empowerment program
|
RAM-based nursing empowerment program for families of children (ages 1-3) after heart surgery.
Includes 5 structured sessions focusing on family empowerment, coping mechanisms, and child development.
|
|
Comparador activo: Control Group
Families who receive routine care and the informative booklet
|
Families in the control group will receive routine care and an educational booklet titled "Family Empowerment Booklet After Cardiac Surgery Based on Roy Adaptation Model".
The booklet provides information on care processes and coping strategies.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Developmental Screening Test II (Denver II)
Periodo de tiempo: At months 1, 2, 3, 6, 9, and 12 after the intervention
|
A performance-based test designed to screen children from birth to 72 months for developmental delays.
It evaluates 125 items across four domains: Personal-social, fine motor-adaptive, language, and gross motor skills.
Results are categorized as Normal, Suspected, or Abnormal based on age-standardized performance.
|
At months 1, 2, 3, 6, 9, and 12 after the intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Parental Self-Efficacy Scale (1-3 Years)
Periodo de tiempo: Month 6 and Month 12 post-intervention
|
A 51-item scale measuring parental self-efficacy in seven domains: Emotional Competence, Responsive Sensitivity, Protection, Discipline, Play, Teaching, and Daily Routines/Care.
Scores range from 51 to 255; higher scores indicate stronger parental self-efficacy.
|
Month 6 and Month 12 post-intervention
|
|
Child Growth Parameters (Anthropometric Z-Scores)
Periodo de tiempo: At months 1, 2, 3, 6, 9, and 12 after the intervention
|
Growth parameters including height, weight, and Body Mass Index (BMI).
Standardized Z-scores (Standard Deviation Scores - SDS) will be calculated using WHO Anthro software based on Turkish growth percentiles (Neyzi et al., 2008).
Malnutrition is defined as Z-scores below -2 SD.
|
At months 1, 2, 3, 6, 9, and 12 after the intervention
|
|
Feeding Process Maternal Attitude Scale (FPMAS)
Periodo de tiempo: Month 6 and Month 12 post-intervention
|
This 27-item, 5-point Likert-type scale measures maternal attitudes during the feeding process.
It includes five sub-dimensions: Negative Mood During Meals, Attitudes Toward Inadequate/Unbalanced Nutrition, Negative Feeding Strategies, Forced Feeding, and Reaction to Others' Opinions.
Total scores range from 27 to 135; higher scores indicate more problematic or negative maternal feeding attitudes.
|
Month 6 and Month 12 post-intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Şenay Çetinkaya, Prof. Dr., Cukurova University
Publicaciones y enlaces útiles
Publicaciones Generales
- Demirsoy Horta G, Aksu H, Ozsoy S. Use of Roy's Adaptation Model in women's adaptation to the postpartum period. Ege University Faculty of Nursing Journal (Ege Universitesi Hemsirelik Fakultesi Dergisi). 2017; 33(1):180-190.
- Uzun S. Sister Callista Roy: Adaptation Model. In: Karadag A, Caliskan N, Baykara ZG (eds). Nursing Theories and Models. Istanbul: Akademi Basin ve Yayincilik. 2017: 382-397.
- Elibol F, Magden D, Alpar R. Validity and reliability of the parental self-efficacy scale (1-3 years). Bulletin of Community Medicine (Toplum Hekimligi Bulteni). 2007;26(3):25-31.
- Dilsiz H, Dag I. Feeding Process Maternal Attitude Scale (FPMAS): Development, Validity and Reliability Study. Turk J Pediatr Dis (Turkiye Cocuk Hastaliklari Dergisi). 2020; 14:7-15.
- Yalaz K, Anlar B, Bayoglu B. Denver II developmental screening test "Turkish standardization". Ankara: Developmental Child Neurology Association. 2010; 11-26.
- Alimohammadi N, Maleki B, Shahriari M, Chitsaz A. Effect of a care plan based on Roy adaptation model biological dimension on stroke patients' physiologic adaptation level. Iran J Nurs Midwifery Res. 2015 Mar-Apr;20(2):275-81.
- Goudarzi F, Khadivzadeh T, Ebadi A, Babazadeh R. Women's interdependence after hysterectomy: a qualitative study based on Roy adaptation model. BMC Womens Health. 2022 Feb 13;22(1):40. doi: 10.1186/s12905-022-01615-2.
- Erol Ursavas F, Karayurt O. Effects of a Roy's Adaptation Model-Guided Support Group Intervention on Sexual Adjustment, Body Image, and Perceived Social Support in Women With Breast Cancer. Cancer Nurs. 2021 Nov-Dec 01;44(6):E382-E394. doi: 10.1097/NCC.0000000000000854.
- Neyzi O, Bundak R, Gokcay G, Gunoz H, Furman A, Darendeliler F, Bas F. Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children. J Clin Res Pediatr Endocrinol. 2015 Dec;7(4):280-93. doi: 10.4274/jcrpe.2183.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 154-70
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Desarrollo infantil
-
RenJi HospitalTerminadoRelación de recuento de plaquetas/diámetro del bazo | Clasificación Child-PughPorcelana
-
Stanford UniversityNational Cancer Institute (NCI)TerminadoCarcinoma hepatocelular recidivante | Child-Pugh Clase A | Child-Pugh Clase BEstados Unidos, Japón
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsTerminadoChild-Pugh Clase A | Carcinoma hepatocelular en estadio IIIA | Carcinoma hepatocelular en estadio IIIB | Carcinoma hepatocelular en estadio IIIC | Carcinoma hepatocelular en estadio IVA | Carcinoma hepatocelular en estadio IVB | Child-Pugh Clase BEstados Unidos
-
Boehringer IngelheimYa no está disponibleEnfermedades pulmonares intersticiales (en poblaciones pediátricas) | Enfermedad pulmonar intersticial infantil (chILD)
-
Centre Hospitalier Universitaire DijonTerminadoCarcinoma hepatocelular A de Child-PughFrancia
-
MindRank AI LtdAún no reclutandoInsuficiencia hepática (leve a moderada, de clase A y B según Child-Pugh) | Insuficiencia Hepática (ID MeSH: D048550)Porcelana
-
CatalYm GmbHReclutamientoCarcinoma hepatocelular A de Child-Pugh | Carcinoma hepatocelular irresecable o metastásico | Fracaso del tratamiento de primera línea que incluyó un compuesto anti PD-(L)1 aprobadoItalia, Alemania
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCTerminadoCarcinoma hepatocelular avanzado del adulto | Child-Pugh Clase A | Carcinoma hepatocelular en estadio III | Carcinoma hepatocelular en estadio IIIA | Carcinoma hepatocelular en estadio IIIB | Carcinoma hepatocelular en estadio IIIC | Carcinoma hepatocelular en estadio IV | Carcinoma hepatocelular... y otras condicionesEstados Unidos
-
AstraZenecaTerminadoCáncer gástrico | Neoplasias malignas sólidas avanzadas | Tumor Sólido | Child-Pugh A a B7 Carcinoma hepatocelular avanzado | NSCLC mutante EGFR y/o ROS | Carcinoma de metástasis de pulmónCorea, república de